Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
74 hedge funds and large institutions have $226M invested in Calithera Biosciences, Inc in 2017 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 5 closing their positions.
1,020% more capital invested
Capital invested by funds: $20.1M → $226M (+$206M)
900% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 5
124% more funds holding
Funds holding: 33 → 74 (+41)
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
16% less call options, than puts
Call options by funds: $1.28M | Put options by funds: $1.52M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$35.6M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$19.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.29M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$6.48M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$6.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
-$1.42M |
| 2 |
FSA
Franklin Street Advisors
Chapel Hill,
North Carolina
|
-$432K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$263K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$184K |
| 5 |
Squarepoint
New York
|
-$99.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
First Eagle Investment Management
New York
| – | -$1.42M | -21,905 | Closed |
|
|
TC
77
TFS Capital
West Chester,
Pennsylvania
| – | -$92K | -1,420 | Closed |
|
|
RC
78
RBF Capital
San Francisco,
California
| – | -$55K | -650 | Closed |
|
|
WS
79
Wedbush Securities
Los Angeles,
California
| – | -$34K | -525 | Closed |
|
80
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$33K | -510 | Closed |
|
CALA Hedge Fund Activity: Q1 2017 in Review
74 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q1 2017, worth a combined $226M — up 1,020% from $20.1M a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new CALA positions and 5 closed out — a net gain of 45 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $35.6M. The largest seller was First Eagle Investment Management, exiting entirely with an estimated $1.42M sold.
- 74 institutional investors held Calithera Biosciences, Inc (CALA) as of Q1 2017, up from 33 in Q4 2016.
- Funds reported $226M of Calithera Biosciences, Inc stock for Q1 2017, up 1,020% quarter-over-quarter.
- 50 funds opened new Calithera Biosciences, Inc positions in Q1 2017 and 5 closed out, a net change of +45 holders.
- The largest Calithera Biosciences, Inc buyer in Q1 2017 was Wellington Management Group, an estimated $35.6M added.
- The largest Calithera Biosciences, Inc seller in Q1 2017 was First Eagle Investment Management, an estimated $1.42M sold.
Based on aggregated 13F filings for Q1 2017.